AFIB

0.00010.00%
NL

Niamh Louise Pellegrini

Independent Director

Ms. Niamh Louise Pellegrini serves as Independent Director at Acutus Medical, Inc. since August 10, 2021. She had been Chief Commercial Officer of Nevro Corp. since July 15, 2019 until June 09, 2023 and served as its Senior Vice President since 2023 until June 09, 2023. Ms. Pellegrini is responsible for all global sales and marketing-related activities. From September 2018 to June 2019, Ms. Pellegrini was Vice President of Global Commercial Operations for Abbott Vascular. Prior to Abbott, she was the Chief Executive Officer and President of Autonomic Technologies, Inc. since April 2016 until September 2018. Ms. Pellegrini served as the President of North America at Thoratec Corp. from October 6, 2014 to October 8, 2015. Ms. Pellegrini served as Vice President of Venture Investments at Johnson & Johnson Innovation - JJDC, Inc. She joined Johnson & Johnson in 2009. She has operational experience at Johnson & Johnson in a variety of cross functional roles including sales, marketing, information technology and finance. In most of her career, she has been focused on diagnostic solutions for diabetes at LifeScan where she led strategic planning, portfolio management and the commercial execution of Lifescan’s consumer blood glucose monitoring business. She was responsible for managing LifeScan’s inpatient hospital businesses. She has been Director at Autonomic Technologies, Inc. since April 2016. She served as a Director of ViaCyte, Inc. (also known as Novocell, Inc.). She served as Director of Ventus Medical, Inc. She holds a Bachelor of Science in Finance and a Master of Business Administration from Santa Clara University.

Positions